Benzinga - Thu, 06 May 2021 10:05:03 -0400
Benzinga - Thu, 06 May 2021 08:06:10 -0400
Benzinga - Tue, 04 May 2021 10:12:44 -0400
Benzinga - Mon, 03 May 2021 10:12:13 -0400
Benzinga - Wed, 28 Apr 2021 10:02:30 -0400
Benzinga - Mon, 26 Apr 2021 10:07:32 -0400
Benzinga - Mon, 26 Apr 2021 05:25:18 -0400
load more
Sector: Health Care.Industry: Biotechnology
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.950-1.200 -0.2500
REV0
Q4 2020Est.ActualSurprise
EPS-0.790
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
TARAProtara Therapeutics0.51%110.4M

Protara Therapeutics Company Questions & Answers

Q

How do I buy Protara Therapeutics (TARA) stock?

A

You can purchase shares of Protara Therapeutics (NASDAQ: TARA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Protara Therapeutics's (TARA) main competitors?

A

Other companies in Protara Therapeutics’s space includes: GlycoMimetics (NASDAQ:GLYC), Aziyo Biologics (NASDAQ:AZYO) and Concert Pharmaceuticals (NASDAQ:CNCE).

Q

What is the target price for Protara Therapeutics?

A

The latest price target for Protara Therapeutics (NASDAQ: TARA) was reported by Cowen & Co. on 2020-10-19. The analyst firm set a price target for 50.00 expecting TARA to rise to within 12 months (a possible 408.65% upside). 2 analyst firms have reported ratings in the last year.

Q

How much is Protara Therapeutics (TARA) stock ?

A

The stock price for Protara Therapeutics (NASDAQ: TARA) is $9.83 last updated Fri May 07 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Protara Therapeutics (TARA) dividend?

A

There are no upcoming dividends for Protara Therapeutics.

Q

When is Protara Therapeutics (NASDAQ:TARA) reporting earnings?

A
Protara Therapeutics’s Q2 earnings are confirmed from now on August 2, 2021.
Q

When is the upcoming split for TARA?

A

There is no upcoming split for Protara Therapeutics.